Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanwal Raghav

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
Small Bowel Adenocarcinoma: Etiology, Presentation, and Molecular AlterationsKatrina S Pedersen, Kanwal Raghav, Michael J Overman
Frontiers in Cell and Developmental Biology|October 4, 2023
Mechanisms of resistance to EGFR-targeted therapies in colorectal cancer: more than just geneticsChristine Parseghian, Madhulika Eluri, Scott Kopetz, et al.
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
How quality of life can inform management decisions in later-line metastatic colorectal cancerTanios S Bekaii-Saab, Kanwal Raghav, Zev A Wainberg
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
How quality of life can inform management decisions in later-line metastatic colorectal cancer: Q&ATanios S Bekaii-Saab, Kanwal Raghav, Zev A Wainberg
Cleveland Clinic Journal of Medicine|September 6, 2012
A woman with a swollen uvulaSaurabh Anil Pande, Kanwal Raghav, Shivani Mehta, et al.
JAMA Network Open|August 6, 2021
Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal MesotheliomaKanwal Raghav, Suyu Liu, Michael Overman, et al.
The Oncologist|September 7, 2020
Defining a Distinct Immunotherapy Eligible Subset of Patients with Cancer of Unknown Primary Using Gene Expression Profiling with the 92-Gene AssayKanwal Raghav, Michael Overman, Graham M Poage, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 4, 2021
Underreporting of race/ethnicity in COVID-19 researchKanwal Raghav, Seerat Anand, Anirudh Gothwal, et al.
The Oncologist|March 7, 2015
Challenges of efficacy assessments in pseudomyxoma peritoneaMichael J Overman, Cathy Eng, Kanwal Raghav, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2022
Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance)Kanwal Raghav, Fang-Shu Ou, Alan P Venook, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
Small Bowel Adenocarcinoma: Etiology, Presentation, and Molecular AlterationsKatrina S Pedersen, Kanwal Raghav, Michael J Overman
Frontiers in Cell and Developmental Biology|October 4, 2023
Mechanisms of resistance to EGFR-targeted therapies in colorectal cancer: more than just geneticsChristine Parseghian, Madhulika Eluri, Scott Kopetz, et al.
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
How quality of life can inform management decisions in later-line metastatic colorectal cancerTanios S Bekaii-Saab, Kanwal Raghav, Zev A Wainberg
Clinical Advances in Hematology & Oncology : H&O|March 15, 2022
How quality of life can inform management decisions in later-line metastatic colorectal cancer: Q&ATanios S Bekaii-Saab, Kanwal Raghav, Zev A Wainberg
Cleveland Clinic Journal of Medicine|September 6, 2012
A woman with a swollen uvulaSaurabh Anil Pande, Kanwal Raghav, Shivani Mehta, et al.
JAMA Network Open|August 6, 2021
Clinical Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Malignant Peritoneal MesotheliomaKanwal Raghav, Suyu Liu, Michael Overman, et al.
The Oncologist|September 7, 2020
Defining a Distinct Immunotherapy Eligible Subset of Patients with Cancer of Unknown Primary Using Gene Expression Profiling with the 92-Gene AssayKanwal Raghav, Michael Overman, Graham M Poage, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 4, 2021
Underreporting of race/ethnicity in COVID-19 researchKanwal Raghav, Seerat Anand, Anirudh Gothwal, et al.
The Oncologist|March 7, 2015
Challenges of efficacy assessments in pseudomyxoma peritoneaMichael J Overman, Cathy Eng, Kanwal Raghav, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2022
Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance)Kanwal Raghav, Fang-Shu Ou, Alan P Venook, et al.
Pageof 11